Clinical trial data show that gastrointestinal adverse effectsincluding nausea, vomiting, diarrhea, and abdominal discomfortoccur in 20-50% of patients initiating GLP-1 therapy, with rates varying by specific agent and dose
Early findings also suggest potential benefits in systemic inflammation, kidney function, and metabolic syndrome
Researchers also observed increased food intake, suggesting the peptide may actually work against fat loss goals in some cases
Hector Perez, MD, lead bariatric surgeon at Renew Bariatrics and an advisor at Bariatric Reports, told Healthline that when it comes to weight loss, its too early to call survodutide a game-changer. [W]hile the reported weight loss number is impressive, we already have very strong performers in this category, he said
Schedule your appointment
Out of stock For bulk orders over 100 items enquire here Next-day delivery: order by 3:30pm, Mon-Thu Saturday delivery: order by Fri 3:30pm Next-day delivery: order by 3:30pm, Mon-Thu Saturday delivery: order by Fri 3:30pm Description Transform your aesthetic results with this exclusive bundle offer